Find A Clinical Trial

Disease Type: Hodgkin Disease

Trial ID 11-282
Sponsor ID

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

Principal Investigator
Dipti Patel-Donnelly, MD
3 Locations